• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

FDA Could Approve First CRISPR Treatment Today That Might Cure Sickle Cell

cafead

Administrator
Staff member
  • cafead   Dec 08, 2023 at 10:02: AM
via The FDA is expected to authorize Crispr-based therapy Casgevy for the treatment of sickle cell disease in patients ages 12 years and older.

article source